Study of TVEC in Patients With Cutaneous Squamous Cell Cancer

NCT03714828 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma
Skin Cancer
Keratoacanthoma
Cutaneous Tumor
Skin Cancer, Squamous Cell
Lesion Skin

Interventions

DRUG: Injection of TVEC into target lesions - week 1-2
DRUG: Injection of TVEC into target lesions 3wks after 1st injection
DRUG: Injection of TVEC into target lesions 2wks after 2nd injection
DRUG: Injection of TVEC into target lesions 2wks after 3rd injection

Sponsor

University of Arizona

Collaborators

[object Object]